artesunic acid has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JO; Nguyen, CN; Nguyen, HT; Tran, BN; Yong, CS | 1 |
| Li, Z; Lin, F; Luo, SQ; Qiu, JL; Xiang, M; Zhu, YT | 1 |
| Duarte, D; Nunes, M; Ricardo, S; Vale, N | 1 |
3 other study(ies) available for artesunic acid and paclitaxel
| Article | Year |
|---|---|
Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Humans; Lactic Acid; Nanoparticles; Paclitaxel; Polyglycolic Acid | 2017 |
Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate.
Topics: Antineoplastic Agents; Artesunate; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cathepsins; Cell Death; Cell Line, Tumor; Cell Proliferation; Chloroquine; Chromans; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Gene Knockdown Techniques; Humans; Lysosomes; Paclitaxel | 2021 |
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
Topics: Adenosine Diphosphate; Antimalarials; Antineoplastic Agents; Artesunate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benztropine; Breast Neoplasms; Cell Line, Tumor; Chloroquine; Colonic Neoplasms; Containment of Biohazards; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Fluoxetine; Fluphenazine; Humans; Ki-67 Antigen; MCF-7 Cells; Michigan; NF-kappa B; Paclitaxel; Poly(ADP-ribose) Polymerase Inhibitors; Ribose; Sertraline; Thioridazine | 2022 |